North America Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

North America Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 641 | Pages: 145 | April 2018 | Region: North America


North America Companion Diagnostics Market was worth USD 1.22 million in 2018 and estimated to be growing at a CAGR of 22.25%, to reach USD 3.33 million by 2023. North America accounted for the largest market in terms of region. Factors that favoured the market growth in the region are growing consumer base, improvement in healthcare system and increased awareness.

Companion Diagnostics is developed to determine who would benefit from treatment and it helps in identifying if someone cannot be cured, but also equally can be affected by use of specific drug used for their ailment. Disease treatment has come a long way after various developments in the field of technology which is now combined with healthcare. These medical instruments support the doctors to choose which dosage and treatment should be given to patients according to their necessity.

Companion diagnostics market is currently driven by increase in various treatment procedures, technological advancement in healthcare industry and government initiatives. Scientific knowledge gets advanced with the practical application of treatment, hence for a single drug different companion diagnostic procedures can be approved which is further supporting the market growth. Cost involved in latest technology is acting as restraint for the market.

The North America clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.

Based on geography the North America market is analysed under various regions namely, USA and Canada. USA dominates the North America region for companion diagnostics market with highest number of shares followed by Canada.

Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Companion Diagnostics Market By Region, From 2018-2023 (USD million)
  2. North America Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  3. North America Oncology Market By Region, From 2018-2023 (USD million)
  4. North America Inflammation and Autoimmune Diseases Market By Region, From 2018-2023 (USD million)
  5. North America Cardiovascular Diseases Market By Region, From 2018-2023 (USD million)
  6. North America Central Nervous System Disorders Market By Region, From 2018-2023 (USD million)
  7. North America Virology Diseases Market By Region, From 2018-2023 (USD million)
  8. North America Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  9. North America Immuno Histochemistry Market By Region, From 2018-2023 (USD million)
  10. North America Molecular Diagnostics Market By Region, From 2018-2023 (USD million)
  11. North America Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  12. North America Colorectal Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  13. North America Breast Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  14. North America Lung Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  15. North America Gastric Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  16. North America Melanoma Diagnostics Market By Region, From 2018-2023 (USD million)
  17. North America Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  18. North America In-Situ Hybridization Market By Region, From 2018-2023 (USD million)
  19. North America Real Time PCR Market By Region, From 2018-2023 (USD million)
  20. North America Gene Sequencing Market By Region, From 2018-2023 (USD million)
  21. United States Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  22. United States Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  23. United States Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  24. United States Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  25. Canada Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  26. Canada Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  27. Canada Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  28. Canada Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
Middle East And Africa Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Ov...
Latin America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Asia-pacific Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive B...
Europe Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder...
North America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder) And B...
Middle East And Africa Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Lab...
Latin-America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories...
Asia-Pacific Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories,...
Europe Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories, Refer...
North-America Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (Culture-based, PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospit...
Blood Culture Tests Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018 To ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.